What is Dermazone Solutions?
Dermazone Solutions, Inc. is a prominent player in the nanotechnology sector, recognized for its patented nanosphere delivery systems. These advanced systems are central to its product offerings, including Celazome, Kara Vita, and Hyssop Health. The company operates a state-of-the-art, FDA-registered manufacturing facility in St. Petersburg, Florida, providing comprehensive services such as formulating, private labeling, contract manufacturing, packaging, and fulfillment for both pharmaceuticals and cosmeceuticals. The company's focus on innovation and its robust manufacturing capabilities position it as a key entity in its market.
How much funding has Dermazone Solutions raised?
Dermazone Solutions has raised a total of $424K across 1 funding round:
Debt
$424K
Debt (2021): $424K with participation from PPP
What's next for Dermazone Solutions?
With a substantial large-scale late-stage funding context, Dermazone Solutions is poised for significant expansion and strategic development. The recent major strategic investment likely signals a phase of scaling operations, enhancing research and development, and potentially broadening market reach. This capital will be instrumental in leveraging its patented nanotechnology for new product innovations and strengthening its position in the competitive pharmaceutical and cosmeceutical industries. The company's trajectory suggests a focus on commercializing its existing product lines and exploring new applications for its nanosphere technology.
See full Dermazone Solutions company page
